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ABSTRACT
Background Data: Cauda equina syndrome (CES) is a rare situation and is one of the few surgical
emergencies in neurosurgery. While L4-L5 disc is the most common cause of CES, ependymoma and
schwannoma are the most common tumors affecting cauda equina.
Purpose: To present our experience and outcome of management of cauda equina tumors.
Study Design: A retrospective clinical case study.
Patients and Methods: We operated upon 22 cases with known cauda equina tumors at our institution
in the period between October 2016 and April 2020. All patients were subjected to detailed general,
neurological, and radiological evaluation both preoperatively and postoperatively according to our
follow-up protocol. Moreover, the modified McCormick scale (MMS) has been used for pre- and
postoperative functional evaluation. Patients underwent operation using the posterior midline approach,
with neuromonitoring applied in 50% of patients.
Results: The mean age was 44 ± 12.5 years. Nine (41%) patients were female and 13 (59%) were male.
Ninety-one percent of patients presented with radiculopathy. Fifty percent of cases presented with
schwannoma. Growth total tumor resection was achieved in 20 cases (91%). The last follow-up showed
marked improvement in radiculopathy, motor power deficit, and MMS compared to preoperative values.
Immediate postoperative motor power deterioration was reported in two cases. Recurrence was reported
in one case of ependymoma at a two-year follow-up visit that underwent operation with no further
recurrence after 1-year follow-up.
Conclusion: The data of this study may suggest that most cauda equina tumors are benign and favorable
outcome could be achieved in small-sized lesions with a short history and good preoperative clinical
status. (2020ESJ220)
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INTRODUCTION
Cauda equina syndrome (CES) can be defined
as a disordered function of the cauda equina
composed of lumbar, sacral, and coccygeal
nerve roots surrounding the filum terminale.3 It
is a rare clinical situation and is one of the few
surgical emergencies in neurosurgical practice.7
The clinical presentation of CES includes saddle
sensory deficit with motor, bowel, bladder, and
sexual disorders.17 MRI is a very efficient tool
for diagnosis and differential diagnosis of CES
etiology and is characterized by being highly
sensitive in detecting the lesions, their site, and
size and being simple and noninvasive.15
CES can occur due to compression of cauda
equina rootlets, with the most common cause
being a large central L4-L5 and L5-S1 lumbar
disc herniation. 7,12 Less common causes are
spinal injury, postmanipulation, spinal anesthesia,
space-occupying lesions such as hematoma,
abscess, schwannomas, ependymomas, lipomas,
teratomas, arteriovenous malformations, and
metastasis, ischemic injury, and inflammatory
disorders.7,14 The prognosis in cases with CES
is influenced by many clinical variables such as
duration of symptoms, the timing of surgery, and
severity of symptoms.8
In this study, we present our experience and
clinical outcome in managing intradural cauda
equina tumors in our neurosurgical unit.

PATIENTS AND METHODS
We operated upon 22 patients with known
intradural cauda equina tumors at our university
hospitals between October 2016 and April 2020.
We performed this retrospective study to evaluate
the surgical outcome of this group of patients.
Inclusion criteria included any patient with
low back pain and/or sciatica with or without
neurological deficit proved to have intradural
cauda equine tumor with full clinical and
48

radiological data, complete follow-up, and contact
data. Exclusion criteria included other causes of
CES and contraindication to general anesthesia.
Our institution’s medical records were reviewed
through this period and only 22 patients were
eligible according to our inclusion criteria, while
nine patients were excluded due to incomplete
contact, clinical, radiological, or follow-up data.
The study was approved by the ethical review
board at our institution, and all patients formally
consented before surgery.
All patients were subjected to detailed general and
neurological examination and contrast-enhanced
magnetic resonance imaging (MRI) of the lumbar
spine. Tumor characteristics, tumor level, and
tumor length measured in mm were reported. A
whole spine MRI was performed if drop metastasis
of an ependymoma was suspected. Routine
laboratory investigations were done for all cases.
The neurological status of patients was recorded
carefully, the motor power was graded from 0 to
5 on the motor power scale, and the duration of
complaint was recorded. Operative details were
reported with special attention given to the type
of anesthesia, duration of surgery, operative blood
loss, the degree of tumor resection (total, subtotal,
and partial), and intraoperative complications
if present. Intraoperative neurophysiological
monitoring was used in eleven patients. The
clinical outcome has been assessed using the
modified McCormick scale (MMS) for grading the
neurological function of spinal cord conditions.
Surgical Technique:
Surgery was performed in a prone position under
general anesthesia. A midline skin incision was
done at the desired levels guided by fluoroscopy
in some cases. A subfascial muscle dissection
followed by careful laminectomies of the planned
levels to avoid injury of the dura, especially in large
tumors. The laminectomy is planned to reveal
the whole tumor extending above and below the
tumor margins. A midline dural incision centered
over the tumor and extending beyond the tumor
poles was made, followed by dural hatching using
Vicryl 0.3; under the operative microscope, a
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gentle exploration of the tumor circumference was
carried out to know the tumor attachment, usually
directed from the poles to the center, to achieve
the goal of total removal. Bipolar coagulation
of the tumor under continuous irrigation was
conducted, followed by tumor removal as one
piece in 17 patients or piecemeal in 5 patients.
The tumor attachment was released using sharp
dissection using microscissors and/or arachnoid
knife and microdissectors. However, in 5 patients
with schwannoma, the tumor dissection was not
possible, so we had to cut the nerve rootlets (3
patients) or to leave a small sheet of the tumor
over the nerve rootlets (2 patients). Closure of the
dura using Vicryl 0.3 in a watertight fashion was
performed and the wound was tightly closed in
layers over a suction drain that was removed two
days after surgery.
Intraoperative Neurophysiological Monitoring:
Combined motor and sensory monitoring were
used in 8 cases, whereas motor monitoring was
used alone in only 3 cases. Multimodality spinal
cord monitoring was carried out using free-run
electromyography (EMG), motor evoked potential
(MEP), and continuous somatosensory evoked
potential (SSEP) monitoring. The alarming
signals for evoked potential were more than 50%
reduction of motor nerve amplitude compared to
the baseline MEP, while prolongation of sensory
latency of more than 10% of the recorded baseline
is considered significant. If significant changes
occur during surgery, surgery is stopped for a while
until evoked potential changes return to normal.
Postoperative Care:
Detailed neurological examination after recovery
from anesthesia was performed by the attendant
surgeon daily till discharge from hospital. Patients
were followed up at the outpatient’s clinic after 1,
3, and 6 months, then on a yearly basis. Follow-up
contrast MRI was performed 3 and 6 months after
surgery, then on a yearly basis whenever possible.
At each visit, the following parameters were
reported: motor power, new emerging symptoms,
MMS, and tumor regrowth and or recurrence.
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RESULTS
Twenty-two patients were recruited for this study
with different types of intradural cauda equina
tumors. Nine patients (41%) were females and 13
(59%) were males. The mean age was 44 ± 12.5
(23–65) years. The mean duration of complaint
was 10.1 ± 5.56 (range, 2–24) months. The most
common presenting symptom was radiculopathy
in 91% (N = 20) of the cases, of which 63.6%
(N = 14) were bilateral. Low back pain was present
in 15 patients (68.1%). Low back pain was common
among patients with ependymoma (7 out of 9),
while radiculopathy was common among patients
with schwannoma (10 out of 11). Sphincteric
dysfunctions were observed in 4 cases (18.1%); 3
of them were ependymomas. Motor deficit was
observed in 7 patients (31.8%) and was at the foot
level and it was of grade III or IV in most cases (4
were grade IV and 2 were grade III). Moreover,
the motor deficit was bilateral in 5 patients and
it was common in patients with ependymoma (6
out of 7). Sensory disturbances were reported in
63.6% of cases (N = 14) with saddle anesthesia
or hypoesthesia in 3 cases; they are often bilateral
at L5 and S1 (N = 8) and less common at higher
levels. Preoperative functional evaluation of the
spinal cord according to MMS showed that 14
patients were grade I (neurologically intact), 5
patients were grade II (motor weakness grade
IV and/or saddle hypoesthesia), 2 patients were
grade III (motor weakness grade III and saddle
anesthesia in one patient), and 1 patient was grade
IV (motor weakness grade II). We had no patients
graded as grade V (Table 1).
According to MRI, the reported tumor levels were
as follows: L1-L2 in 3 cases, L2-L3 in 4 cases, L3L4 in 9 cases, and L4-L5 in 6 cases. The mean
tumor length was 38.77 ± 10.52 (range, 20–60)
mm. Operative data showed that operative time
was 160 ± 0.48 hours (range, 90–27) minutes and
the operative blood loss was 275 ± 130 (range, 330–
650) ml. The mean hospital stay was 3.5 ± 1.97
(range, 2–7 days). All specimens of patients
49
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reported in this study were benign. Schwannoma
was reported in 11 patients, including an ancient
schwannoma (Figure 1), ependymomas in 9
patients (Figure 2), dermoid tumor in one patient
(Figure 3), and mature teratoma in one patient
(Figure 4).
The mean follow-up period in this series was
19.95 ± 6.9 (range, 10–36) months. At last followup, radicular pain showed marked improvement in
all cases with mild residual paresthesia in 4 patients
(18.1%) out of 20 cases reported preoperatively.
Motor weakness improvement was reported in 6
cases of 7 at the last follow-up. Five patients had
normal motor power, whereas one patient had
weakness of foot dorsiflexion that improved from
grade III preoperatively to grade IV. Two patients
reported immediate postoperative aggravated
motor deficit, one patient who was grade III
deteriorated to grade II and then improved to
grade IV, while the other one who was also
grade III deteriorated to II and then regained the
preoperative grade III. Both were among the cases
of ependymoma and had a preoperative duration
of symptoms of more than two years.
Sphincteric disturbances showed significant
improvement at the last follow-up, with only one
patient having permanent urinary urgency. Sensory
dysfunctions showed significant improvement as
two of the three patients with saddle hypoesthesia
showed marked improvement of their preoperative
sensory changes.
Although statistically insignificant, it has been
observed that there has been a correlation between
clinical outcome and duration of symptoms,
good preoperative neurology, and tumor length,
indicating that the outcome is better in cases
with smaller tumor size and cases with shorter
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complaint duration. In all cases with postoperative
neurological deficit, the tumor was larger than
40 mm in length and the complaint duration was
more than 18 months. In our study, no correlation
was observed between the clinical outcome and
tumor level.
At the last follow-up and according to MMS,
19 patients were grade I (neurologically intact,
ambulated normally, and probably having
minimal dysesthesia), 2 patients were grade II
(who maintained functional independence with
mild motor or sensory deficit, one patient with
persistent saddle anesthesia and the other patient
with postoperative motor power grade IV), and
1 patient was grade III (who had postoperative
power grade III at foot level that led to limitation
of function but still independent). No patients
were graded as grade IV (severe motor or sensory
deficit, dependent) or grade V (paraplegic) (Table
1).
Neurophysiological monitoring was applied in
11 patients, with reported significant changes
during surgery in one case that was very close to
the conus medullaris. We stopped surgery for 10
minutes till changes returned to normal baselines
with no subsequent changes. This was attributed
to the attachment of tumor to the conus, resulting
in tension upon the conus when we were removing
the mass.
There were no reported intraoperative morbidity
in this series and no reported intraoperative or
postoperative mortality. There was only one case
of ependymoma that recurred 2 years after surgery
and reoperation was done with no reported
recurrence during another one year of follow-up
after the second surgery.
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Table 1. Summary of perioperative patient data (N = 22)
Variable
Age/years
Male/female
Low back pain
Radiculopathy
Sphincteric disfunctions
Preoperative weakness
Sensory dysfunctions
Grade I
Grade II
MMS
Grade III
Grade IV
Recurrence

Preoperative number (%)
44 ± 12.5 (23–65)
13 (59)/9 (41)
15 (68.1)
20 (91)
4 (18.2)
7 (31.8)
14 (63.6)
14 (63.6%)
5(22.7%)
2(9.1%)
1(4.5%)
NA

Postoperative number (%)
NA
NA
2 (9%)
4 (18.1%)
1 (4.54%)
2 (9%)
1 (4.5%)
19 (86.4%)
2 (9.1%)
1 (4.5%)
0 (0%)
1 (4.54%)
Figure 1. A case of ancient
schwannoma that was
removed totally with
no complications. (A)
Preoperative MRI T2
sagittal image showing
mixed intensity mass
opposite to L3-L4 segment.
(B) Intraoperative image
of the removed mass. (C)
Postoperative MRI T1
image sagittal view showing
total tumor removal
that was done 6 months
postoperatively.

Figure 2. A case of ependymoma that was removed totally as one mass in a 51-year-old female patient. (A, B)
Preoperative MRI T1-weighted image with contrast sagittal and axial images with homogenous contrast enhancement
opposite L2-L3 segment. (C) Operative view of the removed tumor as a single mass. (D) Postoperative MRI sagittal
T2 image that was done 3 months postoperatively showing total tumor removal.
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Figure 3. A case of dermoid
tumor that was removed totally
as one mass in a 34-year-old
female patient. (A) Preoperative
MRI T2 sagittal image with
a mass opposite L1-L2
segment with a solid and cystic
component. (B) Intraoperative
photo of the removed lesion. (C)
Postoperative MRI sagittal T1
image that was done 3 months
postoperatively showing total
tumor removal.

Figure 4. A case of mature
teratoma that was removed
totally with no complications
in a 46-year-old female
patient. (A, B) Preoperative
MRI T1-weighted sagittal and
axial images with IV contrast
showing heterogeneous contrast
enhancement opposite to L2-L3
segment. (C) Postoperative MRI
T2 sagittal image that was done
3 months after surgery showing
total tumor removal.

DISCUSSION
In this study, we reported 22 patients with known
cauda equine tumors that were operated on in
our department. All cases were operated on at
the proper time with special consideration of the
clinical presentation and tumor size. In general, the
results were satisfactory regarding improvement
of clinical picture with no reported mortality
and only one case of recurrence. All cases were
benign tumors and there was one case of ancient
schwannoma.
In a study performed by Shimada et al.,16 including
28 cases, the duration of complaint ranged from 1
to 93 months with a mean of 22 months. The most
common presentation was either pain in the lower
back or radiculopathy; weakness was reported in 8
52

cases, sensory in 8 patients, and bladder dysfunction
in 9 patients. In this series, schwannoma was
present 82% of patients, and most tumors were
located between L1 and L3. They concluded that
tumor size is of great importance in determining
the clinical symptoms and directly correlates with
symptom duration and severity. The tumor size
in this study ranged from 10 mm to 50 mm, with
only four cases exceeding this size and reaching up
to 150 mm.
Wostrack et al.20 performed a study to evaluate
the clinical presentation and surgical outcome
in cases of cauda equina and conus medullaris
tumors. The series included 27 cases of nerve
sheath tumors, 17 cases of ependymoma, and
9 cases of meningioma. The median duration
of symptoms was 24 months and ranged from 4
days to 20 years. The most common presentation
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was pain. Improvement was lower than that
in our series (62%), which could be due to the
inclusion of conus medullaris tumors. They found
ependymoma surgery to be associated with higher
morbidity. Total tumor removal was achieved in
88% of cases. They found that cases with complaint
duration >1 year (50% improvement) have a worse
outcome than those with duration <1 year (65 %
improvement). Therefore, they concluded that the
longer duration between surgery and diagnosis, in
addition to the preoperative neurological deficits,
negatively affects the surgical outcome and advised
early surgery.
Das et al.6 reported 92 cases with cauda equina
tumors. Ependymoma represented 73% of cases;
the median age was 49 years. They concluded
that surgery is a must in these tumors and that
younger patients and early surgical intervention
are associated with good surgical outcome.
Kobayashi et al. 12 reported 80 patients with
ependymoma. Most cases were grade II;
recurrence occurred in 80% of cases with grade
III tumor and 10% of cases with grade I and
grade II. Postoperative radiotherapy was used in
8 cases, including 5 of grade III and 3 of grade I.
They concluded that good surgical outcomes had
been reported in cases with better preoperative
neurological status and in patients who underwent
early surgery.
Abdulaziz et al.1 performed a retrospective study,
including 58 patients harboring myxopapillary
ependymoma. The mean age was 40.8 years, and
the median follow-up was 51.5 months. According
to the degree of tumor resection, the classification
included three subtypes en bloc in 46.5% (27
cases), gross total removal in 34.5% (20 cases),
and subtotal removal in 18.9% (11 cases). There
were no recurrences in the first group, while 15%
(3 cases) and 45% (5 cases) showed recurrence in
the second and third groups, respectively. They
used radiotherapy in 12 cases. They recommended
tumor removal as one mass, including the tumor
capsule, to avoid recurrence.
A retrospective study performed by Klekamp11
included 42 cases with filum terminal ependymoma.
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Gross total resection was performed in 28 cases
(77.7%), whereas subtotal removal was performed
in the other cases. Radiotherapy was employed
in 6 cases: 5 of them had subarachnoid seeding.
Postoperative bladder dysfunction happened
in 3 cases, while 7 cases sustained the same
preoperative neurological deficit and improvement
occurred in the remaining cases. Five patients died
during follow-up; of them, 2 deaths were related
to the tumor. The author concluded that the most
important factor against postoperative recurrence
is gross total removal and encapsulation of the
tumor. In this study, postoperative radiotherapy
was performed in 6 cases; all the tumors were
unencapsulated and 5 patients had subarachnoid
dissemination.
Fugii et al.9 reported 22 cases with cauda equina
schwannoma to study the relationship between the
tumor size and the clinical syndrome. Small tumors
occupying less than 10% of the cross-sectional
area of the spinal canal are asymptomatic, while
tumors occupying more than 20% in the axial
plane or more than 40% in the sagittal plane can
give rise to the clinical manifestations of either
pain or neurological deficit.
In our series, we have reported one case of ancient
schwannoma. According to our knowledge, only
3 studies have reported ancient schwannoma as
case reports in the literature.2,5,19 Wierzbicki et al.19
reported an ancient schwannoma case complaining
of radiculopathy and urine incontinence for
one month. The tumor was removed totally
as one mass where the size of the tumor was
19 × 28 × 20 mm. Ancient schwannoma is a rare
variant (<1%).2 It is a benign tumor arising from
a nerve sheath originating from the Schwann cells
overlying the peripheral nerves.5 It is associated
with type 1 neurofibromatosis in about 20% of
patients.4 It is more common in females between
the second and fifth decades of life.18 The most
common locations are the head and neck, cervical
region, pelvis, retroperitoneum, and flexor part
of the limbs.2,10 Our ancient schwannoma patient
was a 58-year-old male patient who complained
of severe bilateral sciatica and urinary urgency.
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He had a large mass opposite L3-L4 (Figure 1)
that was removed totally with no complications
and the patient was greatly improved with mild
postoperative dysesthesia.
This study has some limitations, including the
retrospective nature, the small sample size,
the short-term follow-up, and the shortages of
detailed histopathological data and adjuvant
therapy. Further prospective multicenter studies
with a large sample size and long-term follow-up
are highly recommended.

CONCLUSION
The data of this study may suggest that most cauda
equina tumors are benign and favorable outcomes
could be achieved in small-sized lesions with a
short history and good preoperative clinical status.
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الملخص العربى
اورام شبيه ذنب الفرس داخل االم الجافية في االنسان خبرة جراحية لفريق صغير من الجراحين بجامعة بنها

البيانـات الخلفيـة :متالزمـة ذيـل الفـرس هـي حالـة نـادرة وهـي واحـدة مـن حـاالت الطـوارئ الجراحيـة الصغيـرة فـي
شـيوعا لــمتالزمة ذيـل الفـرس  ،فـإن الـورم البطاني
جراحـة األعصـاب .فـي حيـن أن القـرص  L4-L5هـو السـبب األكثـر
ً
شيوعا التي تصيب ذيل الفرس.
العصبي والورم الشفاني هما أكثر األورام
ً
الغرض :تقديم خبرتنا ونتائج عالج أورام ذيل الفرس.

تصميم الدراسة :دراسة حالة سريرية بأثر رجعي.

المرضـى والطـرق :قمنـا بإجـراء  22حالـة مـع أورام ذنـب الفـرس المعروفـة فـي مؤسسـتنا فـي الفتـرة مـا بيـن أكتوبر
 2016وأبريـل  .2020خضـع جميـع المرضـى لتقييـم مفصـل عـام وعصبـي وأشـعاعي علـى حـد سـواء قبـل الجراحـة
وفقـا لبروتوكـول المتابعـة الخـاص بنـا .تـم اسـتخدام مقياس ماكورميـك المعـدل ) (MMSللتقييم الوظيفي
وبعدهـا ً
أيضا .تم تشـغيل المرضى من خالل نهج خط الوسـط الخلفي مع المراقبة العصبية في
قبل وبعد العملية الجراحية ً
 ٪ 50من المرضى.

النتائج :كان متوسط العمر  12.5 ± 44سنة .تسعة ( )٪ 41من المرضى كانوا من اإلناث و  )٪ 59( 13من الذكور.
واحـد وتسـعون فـي المئـة مـن المرضـى يعانـون مـن اعتلال الجـذور .تـم عـرض خمسـين بالمائـة من الحـاالت المصابة
ملحوظا
ً
بورم شفاني .تم تحقيق استئصال الورم الكلي للنمو في  20حالة ( .)٪91أظهرت المتابعة األخيرة تحسنً ا
ً
مقارنـة بما قبـل الجراحة .تم اإلبالغ
فـي كل مـن اعتلال الجـذور  ،وعجـز القـوة الحركيـة  ،والرسـائل متعـددة الوسـائط
عن تدهور فوري في قوة المحرك بعد الجراحة في حالتين .تم اإلبالغ عن ارتجاع في حالة واحدة من الورم البطاني
العصبي في سنتان من المتابعة وتم إجراء الجراحة دون تكرار آخر بعد سنة واحده من المتابعة.
الخالصـة :قـد تشـير بيانـات هـذه الدراسـة إلـى أن معظـم أورام ذيـل الفـرس حميـدة ويمكن تحقيق نتائـج إيجابية في
اآلورام صغيرة الحجم ذات التاريخ القصير والحالة السريرية الجيدة قبل الجراحة.
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